ITUS (ITUS) Reaches $2.73 After 5.00% Up Move; Moore Medical (MMD)’s Sentiment Is 1.9

December 9, 2017 - By Marguerite Chambers

The stock decreased 0.20% or $0.04 during the last trading session, reaching $20.18. About 45,436 shares traded. MainStay DefinedTerm Municipal Opportunities Fund (MMD) has declined 0.25% since December 9, 2016 and is downtrending. It has underperformed by 16.95% the S&P500.

The stock of ITUS Corporation (NASDAQ:ITUS) is a huge mover today! The stock increased 5.41% or $0.14 during the last trading session, reaching $2.73. About 100,641 shares traded. ITUS Corporation (NASDAQ:ITUS) has declined 67.95% since December 9, 2016 and is downtrending. It has underperformed by 84.65% the S&P500.The move comes after 7 months positive chart setup for the $45.21M company. It was reported on Dec, 9 by Barchart.com. We have $2.87 PT which if reached, will make NASDAQ:ITUS worth $2.26 million more.

Summit Financial Wealth Advisors Llc holds 0.23% of its portfolio in MainStay DefinedTerm Municipal Opportunities Fund for 29,850 shares. Usca Ria Llc owns 73,206 shares or 0.18% of their US portfolio. Moreover, Regal Investment Advisors Llc has 0.11% invested in the company for 21,710 shares. The Colorado-based Advisors Asset Management Inc. has invested 0.08% in the stock. Botty Investors Llc, a Illinois-based fund reported 12,820 shares.

ITUS Corporation funds, develops, acquires, and licenses emerging technologies in the areas of biotechnology. The company has market cap of $45.21 million. The company, through its subsidiary, Anixa Diagnostics Corporation, is developing a platform called Cchek, a series of non-invasive, blood tests for the early detection of solid tumor based cancers. It currently has negative earnings. It has a collaborative research agreement with The Wistar Institute for the development and validation of Cchek.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.